General MedicationsTABLETGeneric

MILNACIPRAN HYDROCHLORIDE

Standard Dose

25MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: None (Tentative Approval)

Summary

Approval overview MILNACIPRAN HYDROCHLORIDE is listed in Drugs@FDA under application 207399 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient MILNACIPRAN HYDROCHLORIDE Form and strength TABLET - 25MG Sponsor STRIDES PHARMA GLOBAL PTE LIMITED Submission history Latest submission status date: 2026-03-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview MILNACIPRAN HYDROCHLORIDE is listed in Drugs@FDA under application 207399 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient MILNACIPRAN HYDROCHLORIDE Form and strength TABLET - 25MG Sponsor STRIDES PHARMA GLOBAL PTE LIMITED Submission history Latest submission status date: 2026-03-09 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.